TP53 and neoplasm: The subsequent development by the Old Laboratory of an anti-p53 monoclonal antibody led this group to demonstrate its widespread expression in a variety of tumor cell lines, its nuclear localization, and the fact that its elevated expression was associated with the active proliferation of cells.